Soo Y. Cheong
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 01, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.
Journal: Lancet (London, England)
Published: March 25, 2024
Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate-to-Severe Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 04, 2017
Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4.
Journal: Annals of the rheumatic diseases
Published: April 03, 2017
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: August 25, 2016
Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: response to letter by Scheinberg and Azevedo.
Journal: Annals of the rheumatic diseases
Published: July 20, 2016
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.
Journal: Annals of the rheumatic diseases
Published: March 13, 2015
An eQTL biological data visualization challenge and approaches from the visualization community.
Journal: BMC bioinformatics
Published: May 22, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026